Patent details

EP2820151 Title: CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS

Basic Information

Publication number:
EP2820151
PCT Application Number:
US2013027441
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137075271
PCT Publication Number:
WO2013130364
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
French Title of Invention:
SÉLECTION DE PATIENTS ATTEINTS D'UN CANCER POUR ADMINISTRER DES INHIBITEURS DE SIGNALISATION DE LA VOIE WNT AU MOYEN DE L'ÉTAT DE MUTATION RNF43
German Title of Invention:
KREBSPATIENTENAUSWAHL ZUR VERABREICHUNG VON WNT-SIGNALÜBERTRAGUNGSHEMMERN UNTER VERWENDUNG EINER RNF43-STATUS-MUTATION
SPC Number:

Dates

Filing date:
22/02/2013
Grant date:
25/03/2020
EP Publication Date:
07/01/2015
PCT Publication Date:
06/09/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2020
EP B1 Publication Date:
25/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/02/2021
Expiration date:
22/02/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
LIU, Jun
Address:
United States (US)

2

Name:
HSIEH, Hsin-i
Address:
United States (US)

3

Name:
JIANG, Xiaomo
Address:
United States (US)

4

Name:
HAO, Huaixiang
Address:
United States (US)

5

Name:
CONG, Feng
Address:
United States (US)

6

Name:
NG, Nicholas
Address:
United States (US)

Priority

Priority Number:
201261604290 P
Priority Date:
28/02/2012
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/68;

Publication

European Patent Bulletin

1

Issue number:
202013
Publication date:
25/03/2020
Description:
Grant (B1)

2

Issue number:
202103
Publication date:
20/01/2021
Description:
Opposition procedure started

3

Issue number:
202224
Publication date:
15/06/2022
Description:
Termination of the opposition

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages